Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
For our 11th video in the GRACE Spanish Lung Cancer Library,
Dr. Brian Hunis, Medical Director, Head and Neck Cancer Program, Memorial Cancer Institute, Miami, Florida, joined GRACE to discuss the basics of Lung Cancer for Spanish-speaking patients and caregivers, in this video Dr. Hunis reviews lung cancer subtypes.
TRANSCRIPTS - Spanish and English
Subtipos del Cancer de Pulmón
Hay dos tipos muy grandes cancer de pulmón: el cáncer de pulmón de células pequeñas y el cáncer de pulmón de células no pequeñas. Dentro del cancer de pulmón de células no pequeñas, los dos grupos grandes son: el cáncer de pulmón escamoso o epidermoide y el cancer de pulmón no escamoso o no epidermoide, dentro de los cuales el grupo más grande es el adenocarcinoma, el cáncer de pulmón de células grandes y el cáncer de pulmón no identificado (NOS o not otherwise specified).
Lung Cancer Subtypes
There are two big subtypes of lung cancer: small cell lung cancer and non-small cell lung cancer. In non-small cell lung cancer there are two large subtypes that are: squamous or epidermoid lung cancer and non-squamous or non-epidermoid lung cancer in which the largest groups is adenocarcinoma, large cell lung cancer and not specified lung cancer (NOS or not otherwise specified).
Please feel free to offer comments and raise questions in our
discussion forums.
Bispecifics, or bispecific antibodies, are advanced immunotherapy drugs engineered to have two binding sites, allowing them to latch onto two different targets simultaneously, like a cancer cell and a T-cell, effectively...
The prefix “oligo–” means few. Oligometastatic (at diagnosis) Oligoprogression (during treatment)
There will be a discussion, “Studies in Oligometastatic NSCLC: Current Data and Definitions,” which will focus on what we...
Radiation therapy is primarily a localized treatment, meaning it precisely targets a specific tumor or area of the body, unlike systemic treatments (like chemotherapy) that affect the whole body.
The...
Biomarkers are genetic mutations (like EGFR, ALK, KRAS, BRAF) or protein levels (like PD-L1) in tumor cells that help guide personalized treatment, especially NSCLC, directing patients to targeted therapies or immunotherapies...
Hi Stan! So good to hear from you. I'm sorry for the late response. I too have been out of town with family and missed your post, probably because I was...
It is so good to hear from you! And I am so happy to hear that your holidays have been good and that you are doing well. It sounds like your...
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components: